PubMed Health⌕ Search

SEARCH · PubMed Health

Results for “PROGRESSIVE MUSCULAR DYSTROPHY”

Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 271 records · Page 15Linked to original sources

[The use of bemitil in patients with progressive muscular dystrophies].

Bemithyl treatment was carried out in 22 patients with neuromuscular diseases (progressive myodystrophy). The actoprotector bemithyl inhibited in these patients the processes of lipid peroxidation, activation of neoglucogenesis favours improvement of interorganic exchange of metabolites. Bemithyl is recommended in patients with progressive myodystrophy along with drugs normalizing the protein, energy and electrolyte metabolism.

Adolescent↗

Sequential changes of orthogonal electrocardiograms in progressive muscular dystrophy of the Duchenne type.

Sequential changes of orthogonal electrocardiograms in 70 patients with progressive dystrophy of the Duchenne type (PMD) were investigated. The patients were classified into eight stages from the mildest, S(1), to the severest, S(8), according to Swinyard-Deaver's criteria. The most prominent finding was a progressive reduction in R wave amplitude in Lead X (Rx) with advancing severity. It was considered that loss of electrical activity in the left ventricular free wall might be mainly responsible for the reduction in the Rx amplitude. An abnormal Q wave was frequently observed in each stage. Its occurrence remained essentially unchanged with the progression of PMD. Thus, the presence of a deep Q wave cannot serve as an index for assessing the heart involvement, but rather, we conclude that a reduction of the Rx amplitude can be a useful criterion for estimating the extent of cardiac involvement in PMD.

Activities of Daily Living↗